In a somewhat unexpected move with positive implications for the medtech industry, the Federal Reserve (Fed) in September opted for a 0.5% interest rate cut. This major policy action was somewhat exciting because it was a more aggressive reduction than the anticipated standard 0.25% adjustment. In the short term, it had a positive impact on the stock market but other factors will determine the longer-term consequences.